< Back to previous page
Researcher
Diether Lambrechts
- Disciplines (Flanders Institute for Biotechnology):Analysis of next-generation sequence data, Cell death, Cancer biology
- Disciplines (KU Leuven):Morphological sciences, Oncology
- See also: Diether Lambrechts (KU Leuven)
Affiliations
- Laboratory of Translational Genetics (VIB-KU Leuven) (Division)
Responsible
From1 Jan 2017 → Today - VIB-KU Leuven Center for Cancer Biology (Research Center)
Responsible
From1 Jan 2017 → Today - Lambrechts Lab (Research group)
Responsible
From1 Jan 2017 → Today - Laboratory of Translational Genetics (VIB-KU Leuven) (Division)
Member
From1 Jan 2012 → Today - Centre for Molecular and Vascular Biology (Division)
Member
From1 Oct 2003 → 30 Sep 2005 - Department of Cellular and Molecular Medicine (Department)
Member
From1 Oct 1999 → 30 Sep 2003
Projects
1 - 7 of 7
- EXPANDing Immune Cells and their Tumor Antigens during checkpoint immunotherapyFrom1 Jan 2023 → TodayFunding: HORIZON.1.1 - European Research Council (ERC)
- VIB Grant for Lambrechts Lab_Period:2022-01-01-2026-12-31From1 Jan 2022 → TodayFunding: FRI - Project driven research
- CIRCULATING TUMOR DNA AS AN EPIGENETIC BIOMARKER FOR TUMOR RESPONSE’ — ‘INITIATOR’ - ERC POCFrom1 Aug 2020 → 31 Jan 2022Funding: HORIZON.1.1 - European Research Council (ERC)
- RESISTANCE UNDER COMBINATORIAL TREATMENT IN ER+ AND ER- BREAST CANCER.’ — ‘RESCUER’From1 Jan 2020 → TodayFunding: Other EU initiatives out of framework
- 'Advancing a Precision Medicine Paradigm in metastatic Colorectal Cancer: Systems based patient stratification solutions’ — ‘COLOSSUS’From1 Jan 2018 → 31 Dec 2022Funding: Other EU initiatives out of framework
- Exploiting GLIOblastoma intractability to address European research TRAINing needs in translational brain tumour research, cancer systems medicine and integrative multi-omics (GLIOTRAIN) - Marie Sklodowska-Curie actions (ITN)From1 Sep 2017 → 31 Aug 2021Funding: HORIZON.1.2 - Marie Skłodowska-Curie-actions (MSCA)
- VIB Grant for Lambrechts Lab_Period:2017-01-01-2021-12-31From1 Jan 2017 → 31 Dec 2021Funding: FRI - Project driven research
Publications
201 - 210 of 228
- Comparative oncogenomics identifies tyrosine kinase FES as a tumor suppressor in melanoma(2017)
Authors: Michael Olvedy, Flavie Luciani, Bram Boeckx, Jasper Wouters, Florian Rambow, Sara Aibar Santos, Bernard Thienpont, Jasmine Barra, Corinna Kohler, Stein Aerts, et al.
Pages: 2310-2325 - Assessment of concordance between fresh-frozen and formalin-fixed paraffin embedded tumor DNA methylation using a targeted sequencing approach(2017)
Authors: Diether Lambrechts
Pages: 48126-48137 - Chromosomal Instability in Cell-Free DNA as a Highly Specific Biomarker for Detection of Ovarian Cancer in Women with Adnexal Masses(2017)
Authors: Adriaan Vanderstichele, Els Van Nieuwenhuysen, Diether Lambrechts
Pages: 2223-2231 - Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer(2017)
Authors: Bram Boeckx, Diether Lambrechts
Pages: 1767-1778 - A Complex Network of Tumor Microenvironment in Human High-Grade Serous Ovarian Cancer(2017)
Authors: Adriaan Vanderstichele, Bram Boeckx, Diether Lambrechts
Pages: 7621-7632 - Phylogenetic analysis of metastatic progression in breast cancer using somatic mutations and copy number aberrations(2017)
Authors: Diether Lambrechts
Pages: 14944 - Expression profiling of budding cells in colorectal cancer reveals an EMT-like phenotype and molecular subtype switching(2017)
Authors: Bram Boeckx, Eva Galle, Diether Lambrechts
Pages: 58-65 - Amplification of 1q32.1 Refines the Molecular Classification of Endometrial Carcinoma(2017)
Authors: Jeroen Depreeuw, Matthieu Moisse, Michael Dewaele, Jean-Christophe Marine, Diether Lambrechts
Pages: 7232-7241 - Epigenetic effects of carbon nanotubes in human monocytic cells(2017)
Authors: Diether Lambrechts
Pages: 181-191 - Analyses of germline variants associated with ovarian cancer survival identify functional candidates at the 1q22 and 19p12 outcome loci(2017)
Authors: Diether Lambrechts
Pages: 64670-64684
Patents
1 - 10 of 10
- DISEASE DETECTION IN LIQUID BIOPSIES (Inventor)
- BIOMARKERS PREDICTING RESPONSE OF BREAST CANCER TO IMMUNOTHERAPY (Inventor)
- DISEASE DETECTION IN LIQUID BIOPSIES (Inventor)
- PREDICTING CHRONIC ALLOGRAFT INJURY THROUGH AGE-RELATED DNA METHYLATION (Inventor)
- PREDICTING CHRONIC ALLOGRAFT INJURY THROUGH AGE-RELATED DNA METHYLATION (Inventor)
- RETROTRANSPOSON BIOMARKERS (Inventor)
- RETROTRANSPOSON BIOMARKERS (Inventor)
- DISEASE DETECTION IN LIQUID BIOPSIES (Inventor)
- DETECTION OF OVARIAN CANCER IN LIQUID BIOPSIES (Inventor)
- PREDICTING CHRONIC ALLOGRAFT INJURY THROUGH AGE-RELATED DNA METHYLATION (Inventor)